Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
February 9, 2017Thyroid

Effects of Coexistent BRAF V600E and TERT Promoter Mutations on Poor Clinical Outcomes in Papillary Thyroid Cancer: A Meta-Analysis

View Full Paper
Ask AI
Bookmark
Share

Authors

SMShinje MoonHanyang University Seoul HospitalYSYoung Shin SongSeoul Metropolitan GovernmentYKYe An KimSeoul National University

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Moon et al. (2017) studied this question.

synapsesocial.com/papers/69d7d6d65c3030ff03d17cb2https://doi.org/10.1089/thy.2016.0350
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Prognostic effects of TERT promoter mutations are enhanced by coexistence with BRAF or RAS mutations and strengthen the risk prediction by the ATA or TNM staging system in differentiated thyroid cancer patients2016 · 194 citations
  2. 2TERT promoter mutations and long-term survival in patients with thyroid cancer2016 · 108 citations
  3. 3BRAFandTERTpromoter mutations in the aggressiveness of papillary thyroid carcinoma: a study of 653 patients2016 · 126 citations
  4. 4Clinicopathological significance of TERT promoter mutation in papillary thyroid carcinomas: a systematic review and meta‐analysis2016 · 57 citations
  5. 5The BRAFV600E mutation is not associated with poor prognostic factors in Korean patients with conventional papillary thyroid microcarcinoma2005 · 222 citations